Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Taiwanese (TAIEX) Pharma Industry Analysis

UpdatedFeb 16, 2025
DataAggregated Company Financials
Companies52
  • 7D3.5%
  • 3M8.3%
  • 1Y8.3%
  • YTD14.2%

In the last week, the Pharma industry is up 3.4%, with Caliway Biopharmaceuticals up 11%. In the same time, CHO Pharma was down 12%. This means that the industry has gained 7.9% over the past year. As for the next few years, earnings are expected to grow by 54% per annum.

Industry Valuation and Performance

Has the Taiwanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 16 Feb 2025NT$682.8bNT$109.3bNT$11.5b23.6x59.4x6.2x
Tue, 14 Jan 2025NT$603.1bNT$109.3bNT$11.4b21.4x52.7x5.5x
Thu, 12 Dec 2024NT$585.0bNT$109.3bNT$11.4b21.8x51.2x5.4x
Sat, 09 Nov 2024NT$637.8bNT$104.7bNT$8.9b26.7x71.3x6.1x
Mon, 07 Oct 2024NT$632.7bNT$104.7bNT$8.9b26x70.8x6x
Wed, 04 Sep 2024NT$660.4bNT$113.6bNT$9.3b27.7x71x5.8x
Fri, 02 Aug 2024NT$673.1bNT$100.5bNT$6.8b30.9x98.6x6.7x
Sun, 30 Jun 2024NT$694.8bNT$100.4bNT$7.2b32.3x97.1x6.9x
Tue, 28 May 2024NT$622.2bNT$100.4bNT$7.1b28.8x87.1x6.2x
Thu, 25 Apr 2024NT$627.7bNT$101.8bNT$9.4b25.5x67.1x6.2x
Sat, 23 Mar 2024NT$698.8bNT$101.1bNT$9.5b26.1x73.9x6.9x
Mon, 19 Feb 2024NT$613.6bNT$101.6bNT$8.2b24x75.2x6x
Wed, 17 Jan 2024NT$585.9bNT$101.9bNT$7.8b24.2x75.2x5.8x
Fri, 15 Dec 2023NT$571.9bNT$101.6bNT$7.6b24.1x75x5.6x
Sun, 12 Nov 2023NT$563.1bNT$101.8bNT$9.5b20.6x59.3x5.5x
Tue, 10 Oct 2023NT$548.3bNT$101.7bNT$9.6b21.6x57x5.4x
Thu, 07 Sep 2023NT$546.0bNT$101.7bNT$9.6b22x56.7x5.4x
Sat, 05 Aug 2023NT$574.3bNT$98.7bNT$10.1b16.7x57.1x5.8x
Mon, 03 Jul 2023NT$609.6bNT$98.7bNT$10.1b17.4x60.6x6.2x
Wed, 31 May 2023NT$576.1bNT$97.9bNT$11.0b18.1x52.4x5.9x
Fri, 28 Apr 2023NT$559.3bNT$92.1bNT$8.6b22.3x64.7x6.1x
Sun, 26 Mar 2023NT$562.0bNT$90.5bNT$7.9b20.1x70.8x6.2x
Tue, 21 Feb 2023NT$561.3bNT$84.7bNT$7.7b24x73.3x6.6x
Thu, 19 Jan 2023NT$484.3bNT$84.6bNT$7.9b20.6x61.4x5.7x
Sat, 17 Dec 2022NT$489.4bNT$84.6bNT$7.9b21.3x62.1x5.8x
Mon, 14 Nov 2022NT$427.6bNT$83.1bNT$8.0b15.9x53.6x5.1x
Wed, 12 Oct 2022NT$426.3bNT$78.9bNT$4.3b17.2x98.5x5.4x
Fri, 09 Sep 2022NT$463.4bNT$78.9bNT$4.3b18.5x107.1x5.9x
Sun, 07 Aug 2022NT$382.1bNT$76.8bNT$4.4b21.2x86.3x5x
Tue, 05 Jul 2022NT$376.1bNT$76.8bNT$4.4b20.9x86.1x4.9x
Thu, 02 Jun 2022NT$388.3bNT$76.8bNT$4.4b20x88.9x5.1x
Sat, 30 Apr 2022NT$388.6bNT$76.6bNT$6.6b21.2x59.3x5.1x
Mon, 28 Mar 2022NT$401.1bNT$76.6bNT$8.9b20.5x44.9x5.2x
Wed, 23 Feb 2022NT$405.6bNT$76.7bNT$8.5b21.8x47.9x5.3x
Price to Earnings Ratio

47.9x


Total Market Cap: NT$405.6bTotal Earnings: NT$8.5bTotal Revenue: NT$76.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Pharma Industry Price to Earnings3Y Average 70.9x202320242025
Current Industry PE
  • Investors are pessimistic on the Taiwanese Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 58.7x which is lower than its 3-year average PE of 70.9x.
  • The industry is trading close to its 3-year average PS ratio of 5.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 11% per year over the last three years.
  • Revenues for these companies have grown 13% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market-1.29%
Healthcare3.52%
Pharma3.47%
Pharma3.47%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6919 Caliway BiopharmaceuticalsNT$942.0011.5%
+NT$14.9b		256.1%PS3252.9x
6472 Bora PharmaceuticalsNT$905.006.0%
+NT$5.3b		40.3%PE24x
4743 Oneness BiotechNT$84.507.6%
+NT$2.9b		-49.9%PS359.6x
1795 Lotus PharmaceuticalNT$286.002.9%
+NT$2.1b		3.2%PE17.5x
6576 Foresee PharmaceuticalsNT$84.605.8%
+NT$712.0m		-13.5%PS37.8x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6919

NT$942.00

Caliway Biopharmaceuticals

7D

11.5%

1Y

256.1%

6576

NT$84.60

Foresee Pharmaceuticals

7D

5.8%

1Y

-13.5%

6586

NT$61.60

CHO Pharma

7D

-4.8%

1Y

-3.8%

6785

NT$152.00

Alar Pharmaceuticals

7D

3.8%

1Y

-65.1%

6932

NT$16.00

Mercury Biopharmaceutical

7D

-2.7%

1Y

-9.1%

1271

NT$79.30

SunWay Biotech

7D

-6.3%

1Y

-36.5%

4743

NT$84.50

Oneness Biotech

7D

7.6%

1Y

-49.9%

6472

NT$905.00

Bora Pharmaceuticals

7D

6.0%

1Y

40.3%

4119

NT$88.20

SCI Pharmtech

7D

2.6%

1Y

-2.6%

6535

NT$246.00

Lumosa Therapeutics

7D

-4.8%

1Y

60.3%

6467

NT$60.40

Taho Pharmaceuticals

7D

-8.3%

1Y

n/a

4114

NT$33.35

Synmosa Biopharma

7D

-1.8%

1Y

-6.8%

4746

NT$76.30

Formosa Laboratories

7D

3.0%

1Y

-28.0%

1795

NT$286.00

Lotus Pharmaceutical

7D

2.9%

1Y

3.2%

Market Cool On Lotus Pharmaceutical Co., Ltd.'s (TWSE:1795) Earnings

Dec 04
Market Cool On Lotus Pharmaceutical Co., Ltd.'s (TWSE:1795) Earnings

6461

NT$25.75

Intech Biopharm

7D

-4.6%

1Y

-13.9%

3705

NT$54.80

YungShin Global Holding

7D

-0.9%

1Y

17.1%